← Back
$KLRA All transactions

Kailera Therapeutics, Inc.

▲ BUY
10 / 10

Conviction

$ Value

$8.0M

Shares

500,000

Price

$16

Filed

Apr 22

Why this score? (10/10)
  • Open market buy (+3)
  • Trade value >= $5.0M (+3)
  • 10%+ owner (+1)
  • Cluster: 3 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

RTW INVESTMENTS, LP

Title

CIK

0001493215

Roles

10% Owner

Transaction Details

Transaction Date

2026-04-20

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

10,776,820

Footnotes

Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-1 basis and had no expiration date. | Held by certain affiliated funds managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein.

Filing Info

Accession No.

0001231919-26-000390

Form Type

4

Issuer CIK

0002096997

RTW INVESTMENTS, LP's History

Date Ticker Type Value
2026-04-20 KLRA C
2026-04-20 KLRA $8.0M
2026-04-20 KLRA C
2026-04-20 KLRA C
2025-04-30 OBIO $149K
2025-04-29 OBIO $126K

Other Insiders at KLRA (90d)

Insider Bought Sold Last
Kaplan Andrew T. / BAIN CAPITAL INVESTORS LLC $134.4M 2026-04-20
Bain Capital Life Sciences Investors, LLC / Koppel Adam $25.0M 2026-04-20
BAIN CAPITAL INVESTORS LLC 2026-04-20
MILLIGAN JOHN F 2026-04-16
Renaud Ronald C JR
CEO & President
2026-04-16
MACKAY MARTIN 2026-04-16
RTW INVESTMENTS, LP 2026-04-20
Koppel Adam 2026-04-20
Pagan Douglas W.
Chief Financial Officer
2026-04-16
Bain Capital Life Sciences Investors, LLC 2026-04-20
Burgess Paul D.
See Remarks
2026-04-16
Cloghessy Paula
Chief People Officer
2026-04-16
Kaplan Andrew T. 2026-04-20
Clyburn Frank 2026-04-16
Hite Christopher 2026-04-16
Akamine Scott
Chief Legal Officer
2026-04-16
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 2026-04-20
Coleman Jamie Beth
Chief Commercial Officer
2026-04-16
Wasserman Scott M.
Chief Medical Officer
2026-04-16